These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2617602)

  • 1. Trypanosomiasis and encephalitis: possible aetiology and treatment.
    Jennings FW; McNeil PE; Ndung'u JM; Murray M
    Trans R Soc Trop Med Hyg; 1989; 83(4):518-9. PubMed ID: 2617602
    [No Abstract]   [Full Text] [Related]  

  • 2. African trypanosomiasis: treatment-induced invasion of brain and encephalitis.
    Schmidt H; Bafort JM
    Am J Trop Med Hyg; 1985 Jan; 34(1):64-8. PubMed ID: 3882013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis and modulation of the post-treatment reactive encephalopathy in a mouse model of Human African Trypanosomiasis.
    Kennedy PG
    J Neuroimmunol; 1999 Dec; 100(1-2):36-41. PubMed ID: 10695713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of azathioprine to ameliorate post-treatment encephalopathy associated with African trypanosomiasis.
    Hunter CA; Jennings FW; Kennedy PG; Murray M
    Neuropathol Appl Neurobiol; 1992 Dec; 18(6):619-25. PubMed ID: 1488091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma brucei brucei: a long-term model of human African trypanosomiasis in mice, meningo-encephalitis, astrocytosis, and neurological disorders.
    Keita M; Bouteille B; Enanga B; Vallat JM; Dumas M
    Exp Parasitol; 1997 Feb; 85(2):183-92. PubMed ID: 9030668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging findings in human African trypanosomiasis: a four-year follow-up study in a patient and review of the literature.
    Kager PA; Schipper HG; Stam J; Majoie CB
    Am J Trop Med Hyg; 2009 Jun; 80(6):947-52. PubMed ID: 19478256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma brucei rhodesiense infection in vervet monkeys. II. Provocation of the encephalitic late phase by treatment of infected monkeys.
    Schmidt H; Sayer P
    Tropenmed Parasitol; 1982 Dec; 33(4):255-9. PubMed ID: 7164167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of the sleeping sickness trypanosome from chemotherapy by different parts of the brain.
    Raseroka BH; Ormerod WE
    East Afr Med J; 1985 Jul; 62(7):452-8. PubMed ID: 4076024
    [No Abstract]   [Full Text] [Related]  

  • 9. The management of human trypanosomiasis.
    Ogada T
    East Afr Med J; 1972 Dec; 49(12):1023-5. PubMed ID: 4667458
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenothiazines in murine African trypanosomiasis.
    Rice H; Ruben L; Gould S; Njogu AR; Patton CL
    Trans R Soc Trop Med Hyg; 1987; 81(6):932. PubMed ID: 3503414
    [No Abstract]   [Full Text] [Related]  

  • 11. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eflornithine in the treatment of African trypanosomiasis].
    Louis FJ; Keiser J; Simarro PP; Schmid C; Jannin J
    Med Trop (Mars); 2003; 63(6):559-63. PubMed ID: 15077414
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrocardiographic changes in African trypanosomiasis caused by Trypanosoma brucei rhodesiense.
    Jones IG; Lowenthal MN; Buyst H
    Trans R Soc Trop Med Hyg; 1975; 69(4):388-95. PubMed ID: 1216299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Gambian infant with fever and an unexpected blood film.
    Howie S; Guy M; Fleming L; Bailey W; Noyes H; Faye JA; Pepin J; Greenwood B; Whittle H; Molyneux D; Corrah T
    PLoS Med; 2006 Sep; 3(9):e355. PubMed ID: 17002503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Trypanosomiasis in cattle in Upper Volta: epizootiological studies and contributions to the problem of trypanosome tolerance. I. A study of trypanosomiasis occurrence and the use of trypanocidal agents].
    Haase M; Bernard S; Guidot G
    Berl Munch Tierarztl Wochenschr; 1980 Oct; 93(20):400-2. PubMed ID: 7192553
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor].
    Baral TN; Magez S; Stijlemans B; Conrath K; Vanhollebeke B; Pays E; Muyldermans S; De Baetselier P
    Med Sci (Paris); 2006 Nov; 22(11):914-6. PubMed ID: 17101086
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis.
    Jennings FW; Gichuki CW; Kennedy PG; Rodgers J; Hunter CA; Murray M; Burke JM
    Neuropathol Appl Neurobiol; 1997 Jun; 23(3):225-34. PubMed ID: 9223132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of African trypanosomiasis.
    Williamson J
    Trop Dis Bull; 1976 Jul; 73(7):531-42. PubMed ID: 135387
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospects for improving African trypanosomiasis chemotherapy.
    Moore AC
    J Infect Dis; 2005 Jun; 191(11):1793-5. PubMed ID: 15871110
    [No Abstract]   [Full Text] [Related]  

  • 20. Kenyan purple tea anthocyanins and coenzyme-Q10 ameliorate post treatment reactive encephalopathy associated with cerebral human African trypanosomiasis in murine model.
    Rashid K; Wachira FN; Nyariki JN; Isaac AO
    Parasitol Int; 2014 Apr; 63(2):417-26. PubMed ID: 24440762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.